Tablet
- Pink, modified rectangular shape scored tablet, engraved on one side the Boehringer Ingelheim logo & the letters “PRD” & contains 1.0 mg pergolide (as pergolide mesylate 1.31 mg). For the treatment of clinical signs associated with Pituitary Pars Intermedia Dysfunction, PPID (Equine Cushing’s Disease).